NCT Number: NCT06257693
Phase: PHASE1
Trial Summary: The study is to assess whether the Enolen is safe and delivers anti-androgen medication locally in patients that are planning for radical prostatectomy. – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Alessa Therapeutics Inc.
Acronym:
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives